Oncology & Cancer

Molecular MRI aims at component of multiple cancers

A relatively new biomarker called prostate-specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor ...

Oncology & Cancer

PET detects more prostate cancer than conventional imaging

Research presented at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a new molecular imaging agent finds prostate cancer that has spread to other tissues by locking in on ...

Oncology & Cancer

PET/CT captures hidden source of neuroendocrine cancer

The origin of cancer is often obscured by metastases—tumors that have already spread to other tissues. This is especially the case for neuroendocrine tumors (NETs), a malignancy of nerve cells scattered throughout various ...

Oncology & Cancer

Dynamic whole-body PET detects more cancer

Imaging lung cancer requires both precision and innovation. With this aim, researchers have developed a technique for clinical positron emission tomography (PET) imaging that creates advanced whole-body parametric maps, which ...

Oncology & Cancer

Theranostic PET takes on both ovarian and prostate cancer

A first-in-human study revealed at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a powerful new drug finds and attaches itself to the ovarian and prostate cancer cells ...

page 30 from 40